help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 16, 2008
Molecular Endocrinology, doi:10.1210/me.2007-0273
Molecular Endocrinology Vol. 0, No. 2008 200702731-
doi:10.1210/me.2007-0273
Copyright © 2008 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
22/7/1521    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, J.
Right arrow Articles by Cidlowski, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, J.
Right arrow Articles by Cidlowski, J. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Genetics Home Reference

Submitted on May 29, 2007
Accepted on March 28, 2008

DAX-1 selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL dependent manner

Junguo Zhou, Robert H. Oakley, and John A. Cidlowski*

Molecular Endocrinology Group, Laboratory of Signal Transduction, NIEHS/NIH, DHHS, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709

* To whom correspondence should be addressed. E-mail: cidlows1{at}niehs.nih.gov.

The glucocorticoid receptor (GR) mediates virtually all actions of glucocorticoids, and the nature and magnitude of a cell's response to these steroids are determined primarily by hormone concentration and GR signaling capacity. DAX-1 is an orphan nuclear receptor that functions as a corepressor and deletion or mutation of DAX-1 also causes a decrease in glucocorticoid production. However it is unclear if DAX-1 also alters GR function as a transcription factor. Here, we demonstrate that DAX-1 acts as a novel selective GR modulator. It specifically inhibits ligand-dependent GR transactivation with little effect on GR-mediated transrepression. As demonstrated by co-immunoprecipitation and glutathione-S-transferase pull down assays, DAX-1 physically interacts with GR, but this interaction does not influence either ligand-induced GR nuclear translocation or subsequent GR association with glucocorticoid responsive elements. Instead, DAX-1 competes with coactivators such as GRIP1 for binding to the receptor. Specifically, suppression of GR transactivation is mediated by the N-terminal half of DAX-1, and in particular the LXXLL motifs. Thus we demonstrate that DAX-1 directly modulates GR signaling in addition to affecting glucocorticoid hormone levels.


Key words: nuclear receptor • transactivation • transrepression • dexamethasone • GR • DAX-1

NURSA Molecule Pages Link:

Nuclear Receptors:   DAX1  |  GR
Coregulators:   GRIP1
Ligands:   Dexamethasone






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society